title: Protein kinase drugs--optimism doesn't wait on facts.
authors.affiliation: Molecular Informatics, Structure and Design, Pfizer Global R&D, Sandwich, Kent, CT13 9NJ UK.
authors.forename: Colin R
authors.initials: CR
authors.lastname: Groom
authors.forename: Andrew L
authors.initials: AL
authors.lastname: Hopkins
mesh_terms: D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D047428:Protein Kinase Inhibitors; D020301:Vasospasm, Intracranial / Q000188:drug therapy
chemical_list: D004791:Enzyme Inhibitors; D047428:Protein Kinase Inhibitors; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; C049347:fasudil